Narrating the Unspeakable
Making Sense of Psychedelic Experiences in Drug Treatment
DOI:
https://doi.org/10.5617/jea.7365Abstract
The use of psychedelic substances has been described as an ‘unspeakable primary experience,’ one that is personal and ultimately indescribable. The ineffable quality of such an experience, however, does not prohibit or invalidate attempts to explain it. The struggle to narrate one’s experience is instead an important endeavor. But, how does narration work if the psychedelic experience is truly unspeakable? What kind of narratives are possible? What kinds of narrative work do psychedelics foreclose? This article addresses these questions by analyzing narratives generated about the use of psychedelics for drug treatment. Drawing on 16 months of ethnographic research at drug treatment centers in Baja California, Mexico, this article examines what narration looks like in the context of a psychedelic-based drug treatment modality. It pays particular attention to how people in treatment retell – or struggle to retell – their experiences with psychedelics to make sense of them and then articulate them for the researcher. I argue that psychedelic experiences pose a unique challenge for the anthropological study of these substances, particularly their therapeutic use. I show how these experiences resist narrativization in multiple ways, presenting both ethnographic and epistemological obstacles to the production of anthropological knowledge.
![Photographer: Shana Harris (author) Year: 2019 Place: Baja California, Mexico Caption: 5-meO-DMT treatment session](https://journals.uio.no/public/journals/28/article_7365_cover_en_US.jpg)
Downloads
Published
Issue
Section
License
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a https://creativecommons.org/licenses/by-nc-nd/4.0/
that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal, for non-commercial purpose, no derivatives are permitted. (Please not that this license has been used since 1.10.2018 and will be used in the future. Articles published between 1.1.2017-and 30.9.2018 are licensed under CC BY license: https://creativecommons.org/licenses/by/3.0/) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).